IMPALA Webinar available: Identifying Anomalies in Clinical Trial Data with CTAS. Learn more about the open-source R Package that identifies outliers and anomalies efficiently and accurately in clinical trial time series. Visit https://ow.ly/FbG050S79bU
IEEE Industry Standards and Technology Organization (ISTO)’s Post
More Relevant Posts
-
Every clinical trial patient is unique - and so is their placebo response. How are you accounting for the variability that placebo response causes in your clinical trial data? Discover Placebell, the only placebo response technology that helps clinical trials reduce variability 👉 https://lnkd.in/es5tszmy
To view or add a comment, sign in
-
Tomorrow at 8:30 a.m. EST, we will be hosting a webcast to discuss new interim clinical data from our Phase I/II AFFINITY DUCHENNE trial. Learn more: https://lnkd.in/e3eQKvG3
To view or add a comment, sign in
-
Discover how incorporating real-world data (#RWD) into protocol feasibility, site selection, and patient identification processes results in better, more efficient trial design in our recent blog. https://ow.ly/GoOL50TG63z
To view or add a comment, sign in
-
Design more effective clinical trials with Quest lab data. Learn how we can provide insights to help optimize clinical trial planning. https://lnkd.in/gjJ8AdH4
To view or add a comment, sign in
-
Here's a useful article explaining different clinical trial designs https://lnkd.in/eJ-V3QNn
To view or add a comment, sign in
-
CROs play a vital role in clinical data management, and effective oversight is essential to ensure the quality, integrity, and compliance of trial data. In our latest blog, Debra Anderson shares how sponsors can optimize CRO partnerships by addressing key challenges to maximize the success of clinical trials. Read it now: https://lnkd.in/eePDgPKa
To view or add a comment, sign in
-
Long term update of an important clinical trial - Superior LRC resulting from cisplatin at 100 mg/m2 every 3 weeks as compared to 30 mg/m2 per week, maintained at 8 years of followup. At: https://lnkd.in/gZvV-qUZ
To view or add a comment, sign in
-
Are you looking for data on clinical trial trends? You're in the right place! Explore our experts' in-depth analysis of last year's completed clinical trials using data from Trialtrove to gain insight into upcoming trial trends. Download your copy of the infographic here: https://ow.ly/cpg450RTHxH Learn about Trialtrove here: https://ow.ly/9NRL50RTHxF #ClinicalTrials #ClinicalTrialTrends #ClinicalResearch #ClinicalInsights
To view or add a comment, sign in
-
In this commentary, the authors highlight possible issues and solutions to be considered with placebo-controlled designs and primary endpoints as proposed in the recent clinical trial design guidelines for cluster headache: https://lnkd.in/dKkT7H6K
To view or add a comment, sign in
-
Never miss a beat, anytime, anywhere. With ECG data at-home comparable to ECG at sites, we are changing the future of decentralized clinical trial approaches. Learn more: https://lnkd.in/gbf9rzTK
To view or add a comment, sign in
465 followers
More from this author
-
Top 10 Ways Industry Organizations Can Further Technology Innovations and Market Adoption
IEEE Industry Standards and Technology Organization (ISTO) 1mo -
Navigating Tech Alliance Leadership: 6 Trends and Solutions to Consider
IEEE Industry Standards and Technology Organization (ISTO) 2mo -
Top 5 Ways a Consortia Can Generate Non-Dues Revenue
IEEE Industry Standards and Technology Organization (ISTO) 3mo